From: Construct validation of the Research Engagement Survey Tool (REST)
Other measures | Quality | Quantity | ||||
---|---|---|---|---|---|---|
N | Spearman’s R | P value | N | Spearman’s R | P value | |
Medical Mistrust | 322 | 0.11 (negligible) | 0.05 | 325 | 0.12 (negligible) | 0.03 |
Trust in Medical Researchers | 322 | 0.18 (negligible) | < 0.001 | 324 | 0.21 (negligible) | < 0.001 |
Partnership Assessment in community-based Research (PAIR) Measure | 322 | 0.34 (low) | < 0.001 | 325 | 0.44 (low) | < 0.001 |
Kagan Survey of community engagement | 319 | 0.50 (moderate) | < 0.001 | 322 | 0.56 (moderate) | < 0.001 |
Community Engagement in Research Index (CERI) | 320 | 0.19 (negligible) | 0.001 | 323 | 0.25 (negligible) | < 0.001 |
Coalition Self-Assessment Survey (CSAS)—Trusta | 323 | 0.40 (low) | < 0.001 | 328 | 0.42 (low) | < 0.001 |
Partnership self-assessment tool (PSAT) | ||||||
PSAT—Synergy | 325 | 0.61 (moderate) | < 0.001 | 328 | 0.62 (moderate) | < 0.001 |
PSAT—Satisfaction | 324 | 0.61 (moderate) | < 0.001 | 327 | 0.65 (moderate) | < 0.001 |
PSAT—Leadership | 323 | 0.69 (moderate) | < 0.001 | 326 | 0.69 (moderate) | < 0.001 |
PSAT—Efficiency | 323 | 0.62 (moderate) | < 0.001 | 326 | 0.59 (moderate) | < 0.001 |
PSAT—Administration/Management | 323 | 0.63 (moderate) | < 0.001 | 326 | 0.64 (moderate) | < 0.001 |
PSAT—Non-Financial Resources | 322 | 0.47 (low) | < 0.001 | 325 | 0.52 (moderate) | < 0.001 |
PSAT—Financial and Other Capital Resources | 320 | 0.34 (low) | < 0.001 | 323 | 0.32 (low) | < 0.001 |
PSAT—Decision Making | 325 | 0.51 (moderate) | < 0.001 | 328 | 0.51 (moderate) | < 0.001 |
PSAT—Benefits | 324 | 0.33 (low) | < 0.001 | 327 | 0.41 (low) | < 0.001 |
PSAT—Drawbacks | 324 | − 0.21 (negligible) | < 0.001 | 327 | − 0.26 (negligible) | < 0.001 |
PSAT—Comparing Benefits and Drawbacks | 323 | 0.39 (low) | < 0.001 | 326 | 0.42 (low) | < 0.001 |
Wilder Collaboration | 325 | 0.54 (moderate) | < 0.001 | 328 | 0.54 (moderate) | < 0.001 |